BOULDING MARK ELLIOTT (Exec. VP and CLO) sold 2.1% of their position (2.27K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $157.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/8/2026ACC: 0001578852-26-000012
Officer· Exec. VP and CLO
Since Jan 2019
-2.27K
Net shares
Net seller
$157.3K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
2.27K acquired · 4.53K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+2.27K
Price / share
$39.42
Trade value
$89.29K
% of position
2.2%
4/6/2026
105.21K→107.48K
Common Stock
Direct
Shares
−822.00
Price / share
$68.91
Trade value
$56.64K
% of position
0.8%
4/6/2026
107.48K→106.66K
Common Stock
Direct
Shares
−1.44K
Price / share
$69.75
Trade value
$100.65K
% of position
1.4%
4/6/2026
106.66K→105.21K
Total
Net shares
+0.00
Net value
-$68.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/6/2026 | M · Option Exercise | +2.27K | $39.42 | $89.29K | 2.2% | 105.21K | 107.48K |
| Common Stock Direct | 4/6/2026 | S · Sale | −822.00 | $68.91 | $56.64K | 0.8% | 107.48K | 106.66K |
| Common Stock Direct | 4/6/2026 | S · Sale | −1.44K | $69.75 | $100.65K | 1.4% | 106.66K | 105.21K |
| Total | +0.00 | -$68.01K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.27K shares
Shares
−2.27K
Strike price
39.42
Held after
6.80K
Exercisable
—
4/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.27K shares | 4/6/2026 | M · Option Exercise | −2.27K | 39.42 | — | 6.80K |